PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer
Objective Our objective was to examine the association between 18 F-fluorodeoxyglucose
(FDG) uptake on PET scan and prognosis in patients with surgically treated, clinical stage IA …
(FDG) uptake on PET scan and prognosis in patients with surgically treated, clinical stage IA …
New positron emission tomography derived parameters as predictive factors for recurrence in resected stage I non-small cell lung cancer
G Melloni, AMS Gajate, S Sestini, F Gallivanone… - European Journal of …, 2013 - Elsevier
Background The recurrence rate for stage I non-small cell lung cancer is high, with 20–40%
of patients that relapse after surgery. The aim of this study was to evaluate new F-18 …
of patients that relapse after surgery. The aim of this study was to evaluate new F-18 …
Correlation of [18F]‐2‐fluoro‐deoxy‐D‐glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung …
JD Christensen, TV Colby, EF Patz Jr - Cancer, 2010 - Wiley Online Library
BACKGROUND: The aim of the current study was to determine whether the [18F]‐2‐fluoro‐
deoxy‐D‐glucose (FDG) positron emission tomography (PET) standardized uptake value …
deoxy‐D‐glucose (FDG) positron emission tomography (PET) standardized uptake value …
[HTML][HTML] Solid tumor size on high-resolution computed tomography and maximum standardized uptake on positron emission tomography for new clinical T descriptors …
Y Tsutani, Y Miyata, H Nakayama, S Okumura… - Annals of oncology, 2013 - Elsevier
Background To better describe clinical T descriptors using solid tumor size (the maximum
dimension of the solid component of the tumor) on high-resolution computed tomography …
dimension of the solid component of the tumor) on high-resolution computed tomography …
Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography
H Nakamura, H Saji, T Shinmyo, R Tagaya, N Kurimoto… - Lung Cancer, 2015 - Elsevier
Objectives Correlations between maximum standardized uptake value (SUVmax) in
fluorodeoxyglucose positron emission tomography (FDG-PET) and IASLC/ATS/ERS …
fluorodeoxyglucose positron emission tomography (FDG-PET) and IASLC/ATS/ERS …
Difference in prognostic significance of maximum standardized uptake value on [18F]-fluoro-2-deoxyglucose positron emission tomography between adenocarcinoma …
Y Tsutani, Y Miyata, K Misumi, T Ikeda… - Japanese journal of …, 2011 - academic.oup.com
Objective This study evaluates the prognostic significance of [18F]-fluoro-2-deoxyglucose
positron emission tomography/computed tomography findings according to histological …
positron emission tomography/computed tomography findings according to histological …
[HTML][HTML] Prognostic value of metabolic variables of [18F] FDG PET/CT in surgically resected stage I lung adenocarcinoma
XY Wang, YF Zhao, Y Liu, YK Yang, N Wu - Medicine, 2017 - journals.lww.com
Prognostic value of metabolic variables of [18F]FDG PET/CT i... : Medicine Prognostic value of
metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma …
metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma …
Stage III non–small cell lung cancer: prognostic value of FDG PET quantitative imaging features combined with clinical prognostic factors
Purpose To determine whether quantitative imaging features from pretreatment positron
emission tomography (PET) can enhance patient overall survival risk stratification beyond …
emission tomography (PET) can enhance patient overall survival risk stratification beyond …
[PDF][PDF] Role of PET/CT in management of early lung adenocarcinoma
OBJECTIVE. The purpose of this study was to explore the value of FDG PET combined with
high-resolution CT (HRCT) in predicting the pathologic subtypes and growth patterns of …
high-resolution CT (HRCT) in predicting the pathologic subtypes and growth patterns of …
Value of positron emission tomography for lung cancer staging
JM Albes, BM Dohmen, U Schott, E Schülen… - European Journal of …, 2002 - Elsevier
Objective: The therapeutic strategy in non-small-cell lung cancer (NSCLC) requires exact
staging of tumour invasion (T) as well as differentiation between ipsi-and contralateral lymph …
staging of tumour invasion (T) as well as differentiation between ipsi-and contralateral lymph …